Pericardial effusion happens when excess fluid collects in the thin, two-layered sac surrounding the heart. Normally, this sac holds 15 to 50 milliliters of fluid that reduces friction as the heart beats. When something disrupts the balance between fluid production and drainage, that volume can increase dramatically, putting pressure on the heart and interfering with its ability to pump. The causes range from viral infections and autoimmune diseases to cancer, kidney failure, thyroid disorders, and certain medications.
Viral and Other Infections
Viral infection is the single most common infectious cause of pericardial inflammation, which then leads to fluid buildup. Coxsackievirus A and B and hepatitis viruses are among the most frequently identified culprits. In many cases, though, the specific virus is never pinpointed because the illness resolves before extensive testing is done. The infection triggers inflammation in the pericardial lining, and as part of that inflammatory response, fluid leaks into the sac faster than the body can reabsorb it.
Bacterial and fungal infections can also cause effusion, though less commonly. Tuberculosis remains an important cause in parts of the world where it’s prevalent, and it tends to produce larger, more chronic effusions than typical viral cases.
Autoimmune and Inflammatory Diseases
When the immune system attacks the body’s own tissues, the pericardium is a frequent target. The rates are surprisingly high in certain conditions, even though many people never develop symptoms from it.
Lupus is one of the strongest autoimmune drivers. Pericarditis affects up to 50% of lupus patients, and asymptomatic pericardial fluid has been identified in more than half of them on imaging. Most of these effusions are mild and don’t cause hemodynamic problems, but they reflect ongoing inflammation that sometimes flares.
Rheumatoid arthritis causes pericardial involvement in roughly 40% of patients, making it the most common heart-related complication of the disease. About one in three rheumatoid arthritis patients will have an incidental pericardial effusion discovered on imaging even without cardiac symptoms. Systemic sclerosis is another significant cause: autopsy studies show that around 70% of patients had chronic pericarditis or pericardial involvement, though only 5 to 16% ever develop symptoms from it.
Rarer autoimmune contributors include vasculitis (giant cell arteritis causes pericardial involvement in only 1 to 3% of cases) and Sjögren’s syndrome, where pericardial involvement often stays silent and is infrequently reported.
Cancer and Metastatic Disease
Cancer-related pericardial effusion typically results from tumors that have spread to the pericardium rather than tumors originating there. Lung cancer is the most frequent cause, followed by breast cancer, esophageal cancer, pancreatic cancer, melanoma, and blood cancers like B-cell lymphoma.
Cancer cells reach the pericardium in three main ways: direct invasion from a nearby tumor (common with lung cancer growing close to the heart), spread through the bloodstream, or travel through the lymphatic system. Once there, the cancer cells disrupt blood flow in pericardial capillaries and small veins, triggering fluid or blood to accumulate. In some cases, tumors invade the lymph nodes in the chest and block the pericardium’s normal lymphatic drainage, causing a backup of fluid even without cancer cells directly in the pericardial lining.
Kidney Failure and Uremic Toxins
End-stage kidney disease is a potent cause of pericardial effusion. When the kidneys can no longer filter waste, toxic metabolites, nitrogenous waste products, and electrolyte imbalances build up in the blood and damage the pericardium. These toxins trigger inflammatory pathways that injure the pericardial tissue.
The numbers are striking. In one study of 150 patients on hemodialysis, 62% had a pericardial effusion, yet only 7.3% showed clinical or electrical signs of pericarditis. Across broader studies, asymptomatic effusion has been reported in 70 to 100% of patients with uremic or dialysis-related pericarditis. This means fluid buildup around the heart is extremely common in this population and often goes unnoticed until imaging picks it up. The effusion can stem from the pericardial inflammation itself or simply from the fluid overload that comes with failing kidneys.
Hypothyroidism
Severely low thyroid hormone levels cause pericardial effusion in 3 to 37% of hypothyroid patients, depending on severity. The mechanism is distinct from inflammatory causes. Hypothyroidism increases the permeability of blood vessels lining the heart’s surface, letting more protein-rich fluid seep out. At the same time, it slows lymphatic drainage of albumin from the pericardial space. The result is a gradual, often painless accumulation of fluid that can go undetected for a long time because it builds slowly enough for the pericardium to stretch and accommodate it. In rare, severe cases (myxedema), the effusion can become large enough to compress the heart.
Medications
A number of drugs can trigger pericardial effusion through different mechanisms. An analysis of the FDA’s adverse event reporting system identified several with the strongest associations.
Hydralazine, a blood pressure medication, carries one of the highest risk signals. Its effect on the pericardium isn’t from direct toxicity to heart tissue. Instead, it can trigger a drug-induced lupus-like syndrome, where the immune system begins attacking the body’s own tissues, including the pericardium. Minoxidil, another antihypertensive, can cause effusion severe enough to produce chest pain and shortness of breath.
Several cancer treatments also carry risk. Dasatinib, used for certain leukemias, may induce severe effusion in about 1% of patients, likely by increasing the permeability of blood vessels. Arsenic trioxide, used in some leukemia treatments, causes effusion through direct cardiac toxicity. Newer targeted therapies like loncastuximab tesirine carry FDA label warnings for effusion and edema.
Mesalazine, used for inflammatory bowel disease, can cause effusion through allergic reactions or direct cardiotoxic effects. Ibrutinib, a blood cancer drug, interferes with platelet function, and when combined with blood thinners, the risk of hemorrhagic effusion (blood leaking into the pericardial space) rises substantially. Pergolide, once used for Parkinson’s disease, promotes fibrosis and thickening of pericardial tissue.
Heart Attack and Heart Surgery
Injury to heart tissue, whether from a heart attack, cardiac surgery, or chest trauma, can provoke an immune reaction known as Dressler syndrome. The damaged heart cells release proteins that the immune system recognizes as foreign, triggering inflammation of the pericardium and fluid accumulation. Symptoms typically appear weeks to a few months after the initial event, not immediately. This delayed onset often catches people off guard because they assume their recovery is progressing normally.
Effusion can also develop in the days immediately following heart surgery simply from surgical trauma and bleeding near the pericardium, separate from the delayed immune response of Dressler syndrome.
How Effusions Are Classified by Size
On echocardiography, the standard imaging tool for detecting pericardial effusion, the fluid gap between the heart and the pericardium determines severity. A trivial effusion is visible only during the contraction phase of the heartbeat. Mild effusions measure less than 10 millimeters, moderate ones fall between 10 and 20 millimeters, and severe effusions exceed 20 millimeters.
Size alone doesn’t tell the whole story, though. A large effusion that develops slowly over weeks may cause few symptoms because the pericardial sac gradually stretches to accommodate the fluid. A smaller effusion that accumulates rapidly can be far more dangerous because the sac doesn’t have time to expand, and pressure builds quickly on the heart. When that pressure becomes severe enough to impair the heart’s ability to fill with blood, the condition progresses to cardiac tamponade, a medical emergency classically identified by three signs: low blood pressure, distended neck veins, and muffled heart sounds.